Recombinant zoster vaccine coverage in the United States: An analysis of claims-based data-Reference-Cited by-同舟云学术

Recombinant zoster vaccine coverage in the United States: An analysis of claims-based data

Published:2023-05 Issue:23 Volume:41 Page:3493-3496
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Lewis Chad Y.,Mishra Kunal,Sun Yuwei,Sechrist Samantha J.,Arnold Benjamin F.,Acharya Nisha R.^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference18 articles.

1. National and State-Specific Shingles Vaccination Among Adults Aged ≥60 Years;Lu;Am J Prev Med,2017

2. Incidence Rate of Herpes Zoster Ophthalmicus: A Retrospective Cohort Study from 1994 through 2018;Kong;Ophthalmology,2020

3. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines;Dooling;MMWR Morb Mortal Wkly Rep,2018

4. Exumé M. Product Discontinuation NOTICE: ZOSTAVAX® (Zoster Vaccine Live); 2020. https://www.merckvaccines.com/wp-content/uploads/sites/8/2020/06/US-CIN-00033.pdf.

5. Trends and disparity in zoster vaccine uptake in a managed care population;Hechter;Vaccine,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. National trends and disparities in herpes zoster vaccination among US older adults with chronic obstructive pulmonary disease, 2008 to 2022;American Journal of Infection Control;2024-08

2. Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy;Vaccines;2024-01-03